Randomised double blind controlled trial of cyclosporin in multiple sclerosis (Q30495856)

3 November 2017

Randomised double blind controlled trial of cyclosporin in multiple sclerosis (English)

1 reference

3 November 2017

1 reference

Rudge P

1

1 reference

3 November 2017

Koetsier JC

2

1 reference

3 November 2017

Mertin J

3

1 reference

3 November 2017

Mispelblom Beyer JO

4

1 reference

3 November 2017

Van Walbeek HK

5

1 reference

3 November 2017

Clifford Jones R

6

1 reference

3 November 2017

Harrison J

7

1 reference

3 November 2017

Robinson K

8

1 reference

3 November 2017

Mellein B

9

1 reference

3 November 2017

Poole T

10

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 May 1989

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

3 November 2017

1 reference

3 November 2017

52

1 reference

3 November 2017

5

1 reference

3 November 2017

559-565

1 reference

Azathioprine in treatment of multiple sclerosis. Final results of a 41/2-year controlled study of its effectiveness covering 115 patients

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032160

Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032160

Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032160

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032160

Visual evoked response in diagnosis of multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032160

Chronic relapsing experimental allergic encephalomyelitis: cyclosporin-A treatment of relapsing and remitting disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032160

Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032160

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1032160

Preventive and therapeutic effects of cyclosporin and valine2-dihydro-cyclosporin in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat

20 June 2018

1 reference

12 December 2020

Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study

1 reference

12 December 2020

FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS

1 reference

12 December 2020

Assessment of motor function in studies of chronic disability

1 reference

12 December 2020

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

12 December 2020

Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report

1 reference

12 December 2020

Modulation by cyclosporin-A of mononuclear cell distribution during experimental allergic encephalomyelitis

1 reference

12 December 2020

Multiple sclerosis: incorporation of results of laboratory techniques in the diagnosis

1 reference

12 December 2020

The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction

1 reference

12 December 2020

Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.52.5.559

1 reference

3 November 2017

1 reference

3 November 2017

PubMed publication ID

2659736

1 reference